Gastroenterology Division, McMaster University, Health Sciences Centre, Hamilton, ON, Canada.
Aliment Pharmacol Ther. 2009 Jul;30(1):28-36. doi: 10.1111/j.1365-2036.2009.04008.x. Epub 2009 Mar 27.
The prevalence of coeliac disease (CD) may be increased in individuals with dyspepsia, but evidence is conflicting.
To conduct a systematic review and meta-analysis of studies reporting prevalence of CD in dyspepsia.
MEDLINE, EMBASE, and CINAHL were searched up to February 2009. Case series and case-control studies applying serological tests and/or distal duodenal biopsy for CD to unselected adults with dyspepsia were eligible. Prevalence of positive coeliac serology and biopsy-proven CD were pooled for all studies and compared between cases and controls using an odds ratio (OR) and 95% confidence interval (CI).
Fifteen studies were identified. Prevalence of positive coeliac serology was higher in cases with dyspepsia (7.9%) compared with controls (3.9%), but not significantly so (OR for positive endomysial antibodies or tissue transglutaminase 1.89; 95% CI 0.90-3.99). Prevalence of biopsy-proven CD following positive serology was also higher (3.2% in cases vs. 1.3% in controls), but again this was not statistically significant (OR 2.85; 95% CI 0.60-13.38). Prevalence of biopsy-proven CD was 1% in ten studies performing duodenal biopsy first-line.
Prevalence of biopsy-proven CD in subjects with dyspepsia was 1% and was higher than in controls, although this difference was not statistically significant.
乳糜泻(CD)的患病率可能在消化不良患者中增加,但证据相互矛盾。
对报告消化不良患者 CD 患病率的研究进行系统评价和荟萃分析。
检索 MEDLINE、EMBASE 和 CINAHL,截至 2009 年 2 月。符合条件的研究是指对未选择的消化不良成年患者应用血清学检测和/或远端十二指肠活检来诊断 CD 的病例系列和病例对照研究。汇总所有研究中阳性乳糜泻血清学和经活检证实的 CD 的患病率,并使用比值比(OR)和 95%置信区间(CI)比较病例和对照组之间的患病率。
共确定了 15 项研究。消化不良患者中阳性乳糜泻血清学的患病率(7.9%)高于对照组(3.9%),但差异无统计学意义(阳性内肌抗体或组织转谷氨酰胺酶的 OR 为 1.89;95%CI 0.90-3.99)。阳性血清学后经活检证实的 CD 的患病率也较高(病例组为 3.2%,对照组为 1.3%),但差异也无统计学意义(OR 2.85;95%CI 0.60-13.38)。在进行十二指肠活检一线检查的 10 项研究中,经活检证实的 CD 的患病率为 1%。
消化不良患者中经活检证实的 CD 的患病率为 1%,高于对照组,但差异无统计学意义。